Emergence of Infections due to a Polymyxin B-Resistant KPC-2-Producing Klebsiella pneumoniae in Critically Ill Patients: What Is the Role of a Previous Colonization?

Infection Control and Hospital Epidemiology

Volumn 37, Issue 2, 2016, Pages 240-241

  Perez, Leandro Reus Rodrigues ^a,b,c   Dias, Cícero Gomes ^c,d  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c HOSPITAL MÃE DE DEUS   (Brazil)

^d UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEMASE; ERTAPENEM; IMIPENEM; MEROPENEM; POLYMYXIN B; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CLINICAL EVALUATION; CLINICAL PROTOCOL; CRITICALLY ILL PATIENT; DISEASE COURSE; DISEASE SURVEILLANCE; ENTEROBACTERIACEAE INFECTION; GENETIC ANALYSIS; HEALTH SURVEY; HOSPITAL INFECTION; HOST RESISTANCE; HUMAN; INCIDENCE; INTENSIVE CARE; KLEBSIELLA PNEUMONIAE INFECTION; LETTER; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; POLYMYXIN B RESISTANT KPC 2 PRODUCING KLEBSIELLA PNEUMONIAE INFECTION; PREVALENCE; BRAZIL; CRITICAL ILLNESS; CROSS INFECTION; GENETICS; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIOLOGY; RETROSPECTIVE STUDY;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; BRAZIL; CRITICAL ILLNESS; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; POLYMYXIN B; RETROSPECTIVE STUDIES;

EID: 84966348896     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1017/ice.2015.294     Document Type: Letter

References (8)

1. Nordmann P, Naas T, Poirel L. Global spread of carbapenemaseproducing Enterobacteriaceae. Emerg Infect Dis 2011;17: 1791-1798.
2. Carmeli Y, Akova M, Cornaglia G, et al. Controlling the spread of carbapenemase-producing gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect 2010;16: 102-111.
3. Perez LR. Evaluation of polymyxin susceptibility profile among KPC-producing Klebsiella pneumoniae using Etest and MicroScan WalkAway automated system [published online September 11, 2015]. APMIS 2015;123:951-954.
4. Perez LR, Rodrigues D, Dias CG. Evaluation of phenotypic tests to detect carbapenem-resistant Enterobacteriaceae in colonized patients hospitalized in intensive care units. Braz J Infect Dis 2015;19:436-438.
5. Perez LR. Carbapenem-resistant Enterobacteriaceae: a major prevalence difference due to the high performance of carbapenemase producers when compared to the nonproducers [published online October 1, 2015]. Infect Control Hosp. Epidemiol 2015, http://dx.doi. org/10.1017/ice.2015.227. Accessed November 8, 2015.
6. Giannella M, Trecarichi EM, De Rosa FG, et al. Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicenter study. Clin Microbiol Infect 2014;20:1357-1362.
7. Schechner V, Kotlovsky T, Kazma M, et al. Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected? Clin Microbiol Infect 2013;19:451-456.
8. Borer A, Saidel-Odes L, Eskira S, et al. Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenemresistant K. pneumoniae. Am J Infect Control 2012;40:421-425.